Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of cancers. We aimed to evaluate the incidence and prognostic impact of hepatic adverse events (AEs) in a territory‐wide cohort of patients who received ICIs. METHODS: Patients were identified from a territory‐wid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Autores principales: Chan, Stephen Lam, Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Yuen, Becky Wing‐Yan, Luk, Hester Wing‐Sum, Lui, Rashid Nok‐Shun, Chan, Henry Lik‐Yuen, Mok, Tony Shu‐Kam, Wong, Grace Lai‐Hung
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541136/
https://ncbi.nlm.nih.gov/pubmed/32780516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3378
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares